Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged >=75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Trial Profile

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged >=75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Apr 2012 Planned End Date changed from 1 Jan 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 04 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top